Gerd Pluschke
5Patents
2h-index
17Co-inventors
44Inventor score
Filing activity: May 22, 1996 → Dec 2, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5866124A | Antiidiotypic antibodies for high molecular weight-melanoma associated antigen | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7569541B2 | Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7198791B2 | Compositions and methods for the generation of protective immune responses against malaria | Emerging Cross-Sectional Technologies | 1 | Expired |
| US9943583B2 | Proline-rich peptides protective against S. pneumoniae | Chemistry; Metallurgy | 0 | Active |
| US7901687B2 | Antibodies for the detection of Bacillus anthracis and vaccine against B. anthracis infections | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.